Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Study Documents Breakthrough COVID-19 Infections in Vaccinated Healthcare Workers

Lara C. Pullen, PhD  |  March 7, 2022

When the team analyzed the July case rates according to the month in which workers with COVID-19 completed their vaccination series, they found the attack rate for the unvaccinated was higher than that of the vaccinated. The July attack rate among unvaccinated persons was 16.4 per 1,000 persons (95% confidence interval [CI], 11.8 to 22.9). In workers completing vaccination in January or February, the attack rate was 6.7 per 1,000 persons (95% CI, 5.9 to 7.8). This finding stood in contrast to the attack rate of 3.7 per 1,000 persons (95% CI, 2.5 to 5.7) among those who completed vaccination during the period from March through May. Thus, although the vaccination was providing protection against severe disease, it was more effective during the first three months post vaccination.

Dr. Torriani notes the workforce had a mean age of 37 years and the study encompassed “a young cohort of healthcare workers who are quite healthy.” Both vaccinated and unvaccinated workers had symptoms, 83.8% and 88.9%, respectively, but Dr. Torriani reports that when the vaccinated individuals did get sick, they experienced very mild disease.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Disease means that people have to stay home and isolate and not go to work,” Dr. Torriani says. Because of this protocol, the wave of infection put a strain on the healthcare system even though individuals were not particularly ill.

“We’re not worried about severe disease, but we worried about infectious disease in general,” says Dr. Torriani. Thus, she was disappointed when, at their September 2021 meeting, the Advisory Committee on Immunization Practices (ACIP) recommended against booster vaccination for persons with frequent occupational or institutional exposure to SARS-CoV-2.2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

However, Dr. Torriani was grateful when director of the U.S. Centers for Disease Control & Prevention (CDC), Rochelle Walensky, MD, MPH, overruled the ACIP recommendation, enabling healthcare workers to receive a booster dose based on their individual benefits and risks. As justification for her decision, Dr. Walensky cited the implications of waning immunity against infection in healthcare personnel and other frontline workers.

Dr. Torriani says she is pleased by “the current push toward simplifying the criteria for boosters by opening boosters to all adults.”3


Lara C. Pullen, PhD, is a medical writer based in the Chicago area. 

References

  1. Keehner J, Horton LE, Bikin NJ, et al. Resurgence of SARS-CoV-2 infection in a highly vaccinated health system workforce. N Engl J Med. 2021 Sep 30;385(14):1330–1332.
  2. Mbaeyi S, Oliver SE, Collins JP, et al. The Advisory Committee on Immunization Practices’ interim recommendations for additional primary and booster doses of COVID-19 vaccines—United States. MMWR Morb Mortal Wkly Rep. 2021 Nov. 5;70(44);1545–1552.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsProfessional Topics Tagged with:COVID-19health professionalshealthcare workersvaccines

Related Articles

    Vax Hesitancy? Myths & Facts for Patients

    December 16, 2021

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    The End of the Beginning: COVID-19 Vaccines & Other Conundrums

    December 9, 2020

    “It’s like winning Powerball.” For months, there has been a steady trickle of questions from my patients, asking for my opinion about the new vaccines being developed to prevent COVID-19. More to the point, they want to know if they should be vaccinated. ad goes here:advert-1ADVERTISEMENTSCROLL TO CONTINUEAfter some fits and starts, I finally struck…

    Anze Furlan / SHUTTERSTOCK.COM

    How Immunosuppression May Affect COVID-19 Vaccine Response

    June 13, 2021

    Although we can expect to learn much more, preliminary data are now available on the potential safety and effectiveness of COVID-19 vaccines in rheumatology patients. The picture is likely to be nuanced, with not all types of immuno­suppressive treatments having identical impacts on vaccine response. Rheumatologists should use caution in interpreting early reports, while continuing…

    Vaccine Hesitancy: Wariness Is Rare, But There’s a Wider Worry About COVID Vaccines’ Efficacy in Some Populations

    July 6, 2021

    Hesitancy about COVID-19 vaccination persists nationwide, although it varies among regions and sociodemographic groups.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences